Abstract

Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets

Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam

Issue: May/Jun 2022 - Volume 26, Number 3

Page(s): 255-263

Download in electronic PDF format for $75
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 1
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 2
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 3
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 4
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 5
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 6
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 7
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 8
  • Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Page 9

Abstract

Co-processed excipients were prepared by incorporating one excipient into the particle structure of another and a combination of two or more compendia or noncompendia excipients to physically modify their properties, which cannot be achievable by simple physical mixing. The co-processed multicomponent-based excipients were introduced to achieve better characteristics and tableting properties. This objective of this study was to develop and evaluate a co-processed excipient for amlodipine orally disintegrating tablets to simplify the compounding process. The co-processed excipients were prepared by wet granulation with 5% of polyvinylpyrrolidone and croscarmellose sodium, five different percentages of microcrystalline cellulose, and lactose monohydrate. After sieving and drying, the co-processed excipients were evaluated for flowability and compressibility. The co-processed excipients were mixed with the amlodipine powder and magnesium stearate and compressed into tablets. The amlodipine tablets were evaluated for weight variation, content uniformity, thickness, hardness, friability, disintegration, and dissolution tests. Formulation 4 was chosen as the optimum formulation because the results showed this formulation had the excellent flowability and compressibility of a co-processed excipient. It showed uniformity of weight, content, thickness, and hardness, weight loss less than 1%, fast disintegration time, and dissolution results. The developed co-processed excipient can be used by the pharmaceutical industry in the future to compound amlodipine orally disintegrating tablets in a fast and economical way.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2022
Pg. 255-263
Nov/Dec 2023
Pg. 522-527
Jan/Feb 2022
Pg. 80-87
Sep/Oct 2022
Pg. 370-377
Author(s): Ejeta Fikadu
Sep/Oct 2001
Pg. 389-390
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 509-514
Mar/Apr 2022
Pg. 155-162
Mar/Apr 2020
Pg. 148-155
May/Jun 2004
Pg. 181-185
Mar/Apr 2022
Pg. 163-174
Jan/Feb 2015
Pg. 49-56
Author(s): Akers Michael J
Sep/Oct 2024
Pg. 402-407
Sep/Oct 2024
Pg. 423-431
Jul/Aug 2000
Pg. 306-310
Author(s): Allen Loyd V Jr
May/Jun 2023
Pg. 240-249
Jul/Aug 2017
Pg. 293-298
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 431-439
Sep/Oct 2024
Pg. 432-439
Nov/Dec 2023
Pg. 512-521
Jul/Aug 2016
Pg. 283-292